Spots Global Cancer Trial Database for poly (adp ribose) polymerases
Every month we try and update this database with for poly (adp ribose) polymerases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase I Comparative Bioavailability Study | NCT00777582 | Solid Tumors | AZD2281 | 18 Years - 130 Years | AstraZeneca | |
| Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer | NCT00515866 | Pancreatic Neop... | KU-0059436 (AZD... Gemcitabine | 18 Years - | AstraZeneca | |
| Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer | NCT00515866 | Pancreatic Neop... | KU-0059436 (AZD... Gemcitabine | 18 Years - | AstraZeneca |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
